APP and Alzheimer disease: Finally, we have shown that mice that express non-functional CD40L and human APPsw (APP Swedish, a mutant form of APP that increases the production of Aβ), reduce AD-related pathology such as microgliosis, astrocytosis and Aβ load [7].